[go: up one dir, main page]

UA93254C2 - Способ получения препарата инсулина для перорального применения - Google Patents

Способ получения препарата инсулина для перорального применения

Info

Publication number
UA93254C2
UA93254C2 UAA200900222A UAA200900222A UA93254C2 UA 93254 C2 UA93254 C2 UA 93254C2 UA A200900222 A UAA200900222 A UA A200900222A UA A200900222 A UAA200900222 A UA A200900222A UA 93254 C2 UA93254 C2 UA 93254C2
Authority
UA
Ukraine
Prior art keywords
insulin preparation
ranges
producing insulin
insulin
peroral use
Prior art date
Application number
UAA200900222A
Other languages
English (en)
Ukrainian (uk)
Inventor
Андрей Владимирович Артамонов
Петр Иванович Родионов
Original Assignee
Общество C Ограниченной Ответственностью "Концерн 03"
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Общество C Ограниченной Ответственностью "Концерн 03" filed Critical Общество C Ограниченной Ответственностью "Концерн 03"
Publication of UA93254C2 publication Critical patent/UA93254C2/ru

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22Hormones
    • A61K38/28Insulins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/10Inactivation or decontamination of a medicinal preparation prior to administration to an animal or a person
    • A61K41/17Inactivation or decontamination of a medicinal preparation prior to administration to an animal or a person by ultraviolet [UV] or infrared [IR] light, X-rays or gamma rays
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/59Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
    • A61K47/60Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
UAA200900222A 2006-09-13 2007-11-09 Способ получения препарата инсулина для перорального применения UA93254C2 (ru)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU2006132763/15A RU2316339C1 (ru) 2006-09-13 2006-09-13 Способ получения препарата инсулина для перорального применения

Publications (1)

Publication Number Publication Date
UA93254C2 true UA93254C2 (ru) 2011-01-25

Family

ID=39184228

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA200900222A UA93254C2 (ru) 2006-09-13 2007-11-09 Способ получения препарата инсулина для перорального применения

Country Status (13)

Country Link
US (1) US20090312235A1 (ru)
EP (1) EP2067484A4 (ru)
JP (1) JP2010503665A (ru)
CN (1) CN101384276A (ru)
AU (1) AU2007295132A1 (ru)
CA (1) CA2662799A1 (ru)
EA (1) EA012884B1 (ru)
IL (1) IL197470A0 (ru)
MX (1) MX2009001286A (ru)
RU (1) RU2316339C1 (ru)
UA (1) UA93254C2 (ru)
WO (1) WO2008033058A2 (ru)
ZA (1) ZA200807272B (ru)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA90013C2 (ru) 2008-03-19 2010-03-25 Давид Анатолійович Нога Фармацевтическая композиция, содержащая инсулин, и способ его получения
RU2395296C1 (ru) * 2009-02-19 2010-07-27 Общество С Ограниченной Ответственностью "Концерн О3" Способ получения препарата проинсулина для перорального применения
RU2413531C2 (ru) * 2009-03-31 2011-03-10 Общество С Ограниченной Ответственностью "Концерн О3" Способ получения препарата с-пептида проинсулина для перорального применения
RU2441036C1 (ru) * 2010-09-30 2012-01-27 Общество с ограниченной ответственностью Научно-производственное объединение "Перспектива" (ООО НПО "Перспектива") Способ получения активированного полиэтиленоксида
RU2452509C1 (ru) * 2011-01-31 2012-06-10 Общество с ограниченной ответственностью "Саентифик Фьючер Менеджмент" ООО "Саентифик Фьючер Менеджмент" Средство для стимуляции роста организма
CN107007608B (zh) * 2011-12-12 2021-04-23 梅里奥尔医药I公司 I型和ii型糖尿病的治疗

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2066551C1 (ru) * 1994-03-23 1996-09-20 Институт нефтехимического синтеза РАН Способ получения инсулинсодержащих полимерных гидрогелей
RU2117488C1 (ru) * 1997-07-30 1998-08-20 Институт нефтехимического синтеза им.А.В.Топчиева РАН Твердое инсулинсодержащее лекарственное средство
RU2213557C2 (ru) * 2001-12-26 2003-10-10 Закрытое акционерное общество "Аксис" Фармацевтическая композиция, обладающая тромболитическими, противовоспалительными и цитопротективными свойствами

Also Published As

Publication number Publication date
CN101384276A (zh) 2009-03-11
ZA200807272B (en) 2009-07-29
WO2008033058A3 (en) 2008-05-08
MX2009001286A (es) 2009-03-20
CA2662799A1 (en) 2008-03-20
JP2010503665A (ja) 2010-02-04
RU2316339C1 (ru) 2008-02-10
IL197470A0 (en) 2011-08-01
EA012884B1 (ru) 2009-12-30
EA200801259A1 (ru) 2008-08-29
EP2067484A4 (de) 2009-10-28
EP2067484A2 (de) 2009-06-10
AU2007295132A1 (en) 2008-03-20
WO2008033058A2 (en) 2008-03-20
US20090312235A1 (en) 2009-12-17

Similar Documents

Publication Publication Date Title
UA93254C2 (ru) Способ получения препарата инсулина для перорального применения
EP3949969A3 (en) Benzazepine compounds, conjugates, and uses thereof
NZ616304A (en) Immunogenic compositions and methods of using the compositions for inducing humoral and cellular immune responses
CY1118222T1 (el) Συνθεσεις λυασης φαινυλαλανινης αμμωνιας προκαρυωτικων και μεθοδοι αγωγης καρκινου χρησιμοποιωντας συνθεσεις εξ' αυτης
TW200732447A (en) Adhesive formulation, method for the production thereof, and use thereof
EA201171481A1 (ru) Способ получения высококонцентрированного препарата иммуноглобулина для подкожного применения
MX341883B (es) Composicion farmaceutica para el tratamiento y prevencion de canceres.
MY180713A (en) Modified antibody constant region
MX2020012679A (es) Compuestos de amino-pirazincarboxamida, conjugados, y usos de los mismos.
MX369784B (es) Metodo de modificacion del punto isoelectrico de anticuerpos mediante la sustitucion de aminoacidos en region de determinacion de complementariedad (cdr).
WO2007100902A3 (en) Acryloyloxyethylphosphorylcholine containing polymer conjugates and their preparation
WO2009104074A3 (en) Bioconjugates made from recombinant n-glycosylated proteins from procaryotic cells
SG148997A1 (en) Powders comprising low molecular dextran and methods of producing those powders
RU2011144312A (ru) БИСПЕЦИФИЧЕСКИЕ АНТИ-ErbB-3/АНТИ-С-МЕТ АНТИТЕЛА
UA101497C2 (ru) Конъюгаты фактора ix с увеличенным временем полужизни
PL1786400T3 (pl) Kompozycje farmaceutyczne do dostarczania biologicznie czynnych związków metodą kontrolowanego uwalniania
EP1670450B8 (en) Pharmaceutical compositions and method of using levodopa and carbidopa
SG146648A1 (en) Pharmaceutical compositions for treating premature ejaculation by pulmonary inhalation
WO2013012961A3 (en) Sugar alcohol-based crosslinking reagents, macromolecules, therapeutic bioconjugates, and synthetic methods thereof
CA2518971A1 (en) Composition for administration of iron for the treatment of restless legs syndrome
WO2010122246A3 (fr) Procédé de formation d'émulsions à base de polymères de cyclodextrine et de composés lipophiles, émulsions ainsi obtenues, et compositions comprenant lesdites émulsions
RU2012112839A (ru) Новая парентеральная композиция карбамазепина
MX2010006984A (es) Vacunas contra la malaria.
FR2911608B1 (fr) Nouvelles compositions vaccinales anti paludique et ses utilisations.
NO20030073D0 (no) Legemiddelleveringssystem for legemidler som er lite vannopplöselige